By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Medical devices made of PEEK are frequently utilized in spinal and orthopedic operations. Intervertebral discs, joint replacements, and spinal fusion cages are a few examples of PEEK-based implants. These devices are intended to preserve normal spine alignment, promote bone formation, and offer structural support.
The likeness of PEEK-based medical devices to bone in terms of mechanical characteristics, such as elasticity and modulus of elasticity, is one of their advantages. By reducing stress shielding and enhancing load transfer between the implant and the surrounding bone, this similarity can produce superior long-term results.
PEEK is additionally radiolucent, providing for clear viewing of the surrounding tissues and bones during X-ray or MRI imaging. This quality is especially useful for monitoring and evaluating bone healing after surgery.
PEEK is also biocompatible, which means that it is well-accepted by the body and does not cause any noticeable immune responses or negative side effects. This biocompatibility lowers the possibility of immune reaction-related problems or implant rejection.
Overall, the mechanical characteristics, biocompatibility, and radiolucency of PEEK-based medical devices have increased their popularity.
It’s crucial to remember that the precise uses and advantages of PEEK-based devices can change based on the nature of the implant and the requirements of each patient. For specific medical advice and information, speaking with a medical expert is always advised.
The Global PEEK-Based Medical Devices Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Evonik introduces a new PEEK biomaterial for use in medical technology. For the medical technology sector, Evonik has created a novel osteoconductive polyether ether ketone (PEEK) that enhances the fusing between the bone and the implant.
The specialized chemicals business is unveiling a new product line of PEEK-based implant materials of the next generation with the introduction of the novel biomaterial, which it will offer under the trade name VESTAKEEP® Fusion.
The product will be unveiled by Evonik at the online Eurospine conference. Biphasic calcium phosphate, a unique functional additive, was used to create the new PEEK material’s osteoconductive properties, which enable bone cells to adhere to implants more quickly, positively influencing osteointegration at the interface between the bone and the implant. In turn, this will hasten bone fusion and convalescence.
